Open AccessIon channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial
Author(s) -
Eliano Pio Navarese,
Przemysław Podhajski,
Felicita Andreotti,
Giuseppe La Torre,
Robert Gajda,
Adrian Radziwanowski,
Małgorzata Nowicka,
Paweł Bukowski,
Jacek Gajda,
Maciej Omyła,
Piotr Lackowski,
Maciej Piasecki,
Małgorzata Jasiewicz,
Paweł Szymański,
Łukasz Pietrzykowski,
Piotr Michalski,
Aldona Kubica,
Iwona Urbanowicz,
Nicola Orsini,
Max Conte,
Jarosław Pinkas,
Marc A. Brouwer,
Jacek Kubica
Publication year - 2022
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2022.0072
Subject(s) - medicine , hazard ratio , amiodarone , randomized controlled trial , gastroenterology , confidence interval , verapamil , cardiology , atrial fibrillation , calcium